Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-42970
Antimicrob Agents Chemother 2010 Dec 01;5412:5399-402. doi: 10.1128/AAC.00840-10.
Show Gene links Show Anatomy links

Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors.

Bertrand D , Bertrand S , Neveu E , Fernandes P .


???displayArticle.abstract???
Adverse effects have limited the clinical use of telithromycin. Preferential inhibition of the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction (α3β2 and NMJ), the ciliary ganglion of the eye (α3β4 and α7), and the vagus nerve innervating the liver (α7) could account for the exacerbation of myasthenia gravis, the visual disturbance, and the liver failure seen with telithromycin use. The studies presented here enable the prediction of expected side effects of macrolides in development, such as solithromycin (CEM-101).

???displayArticle.pubmedLink??? 20855733
???displayArticle.pmcLink??? PMC2981250
???displayArticle.link??? Antimicrob Agents Chemother



References [+] :
Albuquerque, Mammalian nicotinic acetylcholine receptors: from structure to function. 2009, Pubmed